Glen Santangelo
Stock Analyst at Barclays
(3.32)
# 1,052
Out of 5,124 analysts
111
Total ratings
53.33%
Success rate
2.23%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Overweight | $26 → $24 | $16.92 | +41.84% | 3 | Dec 16, 2025 | |
| ZTS Zoetis | Initiates: Equal-Weight | $136 | $125.82 | +8.09% | 2 | Dec 9, 2025 | |
| XERS Xeris Biopharma Holdings | Initiates: Overweight | $9 | $7.85 | +14.65% | 3 | Dec 9, 2025 | |
| VTRS Viatris | Initiates: Overweight | $15 | $12.45 | +20.48% | 5 | Dec 9, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Overweight | $35 | $31.21 | +12.14% | 5 | Dec 9, 2025 | |
| TDOC Teladoc Health | Initiates: Equal-Weight | $8.5 | $7.00 | +21.43% | 8 | Dec 9, 2025 | |
| TARS Tarsus Pharmaceuticals | Initiates: Overweight | $100 | $81.88 | +22.13% | 1 | Dec 9, 2025 | |
| TALK Talkspace | Initiates: Equal-Weight | $3.5 | $3.63 | -3.58% | 2 | Dec 9, 2025 | |
| PGNY Progyny | Initiates: Overweight | $29 | $25.68 | +12.93% | 5 | Dec 9, 2025 | |
| PHAT Phathom Pharmaceuticals | Initiates: Equal-Weight | $16 | $16.59 | -3.56% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $25.88 | +4.33% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $75.58 | +13.79% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $118 | $91.61 | +28.81% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $3 | $2.71 | +10.70% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $21.71 | +10.55% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $22.63 | +32.57% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $63 | $44.28 | +42.28% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.43 | +4.99% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $58 | $46.30 | +25.27% | 4 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $400 | $337.75 | +18.43% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $243 | $205.50 | +18.25% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8 | $6.95 | +15.11% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $78.94 | +26.68% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $26.79 | +11.98% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.60 | +19.05% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $37.35 | +31.19% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $5.13 | -2.53% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $170 | $156.15 | +8.87% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $7.5 | $7.17 | +4.60% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $960 | $820.29 | +17.03% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $850 | $676.53 | +25.64% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $32.47 | +47.83% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $32.75 | +55.73% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $8.31 | +1,103.37% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $42.14 | +30.52% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.39 | +1,071.55% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.91 | +2,343.99% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.88 | +1,150.00% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $79.36 | - | 3 | Mar 17, 2021 |
Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $16.92
Upside: +41.84%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $125.82
Upside: +8.09%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.85
Upside: +14.65%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.45
Upside: +20.48%
Teva Pharmaceutical Industries
Dec 9, 2025
Initiates: Overweight
Price Target: $35
Current: $31.21
Upside: +12.14%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $7.00
Upside: +21.43%
Tarsus Pharmaceuticals
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $81.88
Upside: +22.13%
Talkspace
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.63
Upside: -3.58%
Progyny
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $25.68
Upside: +12.93%
Phathom Pharmaceuticals
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $16.59
Upside: -3.56%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $25.88
Upside: +4.33%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $75.58
Upside: +13.79%
Dec 9, 2025
Initiates: Overweight
Price Target: $118
Current: $91.61
Upside: +28.81%
Dec 9, 2025
Initiates: Underweight
Price Target: $3
Current: $2.71
Upside: +10.70%
Dec 9, 2025
Initiates: Overweight
Price Target: $24
Current: $21.71
Upside: +10.55%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $22.63
Upside: +32.57%
Dec 9, 2025
Initiates: Overweight
Price Target: $63
Current: $44.28
Upside: +42.28%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.43
Upside: +4.99%
Dec 9, 2025
Initiates: Overweight
Price Target: $58
Current: $46.30
Upside: +25.27%
Dec 9, 2025
Initiates: Overweight
Price Target: $400
Current: $337.75
Upside: +18.43%
Dec 9, 2025
Initiates: Overweight
Price Target: $243
Current: $205.50
Upside: +18.25%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8
Current: $6.95
Upside: +15.11%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $78.94
Upside: +26.68%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $26.79
Upside: +11.98%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.60
Upside: +19.05%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $37.35
Upside: +31.19%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $5.13
Upside: -2.53%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $170
Current: $156.15
Upside: +8.87%
Dec 9, 2025
Initiates: Underweight
Price Target: $7.5
Current: $7.17
Upside: +4.60%
Dec 9, 2025
Initiates: Overweight
Price Target: $960
Current: $820.29
Upside: +17.03%
Dec 9, 2025
Initiates: Overweight
Price Target: $850
Current: $676.53
Upside: +25.64%
Dec 9, 2025
Initiates: Overweight
Price Target: $48
Current: $32.47
Upside: +47.83%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $32.75
Upside: +55.73%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $8.31
Upside: +1,103.37%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $42.14
Upside: +30.52%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.39
Upside: +1,071.55%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.91
Upside: +2,343.99%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.88
Upside: +1,150.00%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $79.36
Upside: -